Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sanofi (SNY) Net Income towards Common Stockholders (2016 - 2026)

Sanofi's Net Income towards Common Stockholders history spans 17 years, with the latest figure at $30.4 million for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 83.37% to $30.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.1 billion, a 3539.21% increase, with the full-year FY2025 number at $9.1 billion, up 53.07% from a year prior.
  • Net Income towards Common Stockholders hit $30.4 million in Q1 2026 for Sanofi, up from -$3.3 billion in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for SNY hit a ceiling of $12.0 billion in Q4 2022 and a floor of -$3.3 billion in Q4 2025.
  • Historically, Net Income towards Common Stockholders has averaged $2.0 billion across 5 years, with a median of $1.8 billion in 2022.
  • The widest YoY moves for Net Income towards Common Stockholders: up 7513.84% in 2025, down 1655.15% in 2025.
  • Tracing SNY's Net Income towards Common Stockholders over 5 years: stood at $12.0 billion in 2022, then crashed by 103.95% to -$472.3 million in 2023, then skyrocketed by 59.73% to -$190.2 million in 2024, then plummeted by 1655.15% to -$3.3 billion in 2025, then surged by 100.91% to $30.4 million in 2026.
  • Business Quant data shows Net Income towards Common Stockholders for SNY at $30.4 million in Q1 2026, -$3.3 billion in Q4 2025, and $3.3 billion in Q3 2025.